MaxWell Biosystems (private company)
See something wrong or missing? Let us know
Offices:Zurich
Industry:
Health services
Manufacturing
Business model:
B2B
MaxWell Biosystems provides next generation high-content electrophysiology platforms to facilitate detailed investigation of cells in vitro. MaxOne and MaxTwo are microelectrode array systems ideally suited to phenotype human iPSC-derived neuronal disease models and screen pharmacological compounds.
Investors:
we tracked 1 investor
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 4.5m
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Belgium
Netherlands
Austria
Germany
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom